Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study.
| Image |  |
|---|---|
| Description | scientific article published on 21 March 2018 |
| Author/s |
author: George R Blumenschein Rachel E Sanborn Christine M. Lovly Karen L. Reckamp |
| Publication date | March 21, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |